Concepedia

Joseph D’Souza

JD

Statistics

Publications

14

Citations

915

H-Index

14

Active since

1985

Affiliations

Novartis (United States)(Current)

UCB Pharma (United States)

Tris Pharma (United States)

UCB Pharma (Belgium)

Novartis (Switzerland)

Joseph D’Souza is an author at Novartis (United States) specializing in pharmacology, antiepileptic pharmacotherapy, and medicine.

Publications per year

1985–2019

14

Publications

14

A Double-Blind, Randomized, Placebo-Controlled Trial of Oxcarbazepine in the Treatment of Bipolar Disorder in Children and Adolescents

Karen Dineen Wagner, Robert A. Kowatch, Graham J. Emslie et al. · American Journal of Psychiatry · 2006 · 247 citations

, , +17

An open-label, prospective, exploratory study of patients with epilepsy switching from levetiracetam to brivaracetam

Stephen L. Yates, Toufic Fakhoury, Wei Liang et al. · Epilepsy & Behavior · 2015 · 154 citations · Full text

, , +14

Safety and tolerability of oxcarbazepine in elderly patients with epilepsy

Ekrem Kutluay, Joseph D’Souza, Ahmad Beydoun · Epilepsy & Behavior · 2003 · 108 citations

, , +12

Effects of oxcarbazepine on sodium concentration and water handling

Rǎjesh C. Sachdeo, Alan G. Wasserstein, Peter J. Mesenbrink et al. · Annals of Neurology · 2002 · 100 citations

, , +14

Reduction of aspirin-induced fecal blood loss with low-dose misoprostol tablets in man

Max M. Cohen, Lorenna Clark, Lynn Armstrong et al. · Digestive Diseases and Sciences · 1985 · 53 citations

, , +3

1–5 of 14